...
首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >A case of doxazosin-induced acute coronary syndrome in a patient with myocardial bridging
【24h】

A case of doxazosin-induced acute coronary syndrome in a patient with myocardial bridging

机译:多沙唑嗪诱发的急性心肌桥患者的一例

获取原文

摘要

Introduction Myocardial bridging (MB) is an anatomical variation characterized by narrowing during systole of some of the epicardial coronary arterial segments running in the myocardium. It can be encountered in 0.5% to 16% of routine coronary angiographies [1]. Although it is considered as a benign anomaly, it may lead to such complications as myocardial ischemia, acute coronary syndromes, coronary spasm, exercise-induced dysrhythmias such as supraventricular tachycardia, ventricular tachycardia, syncope, or even sudden death [2]. In this report, we present a previously unreported case of a 51-year-old man with doxazosin-induced acute coronary syndrome, who was diagnosed with myocardial bridging overlying the left anterior descending artery. Case report A 51-year-old man was admitted to the coronary intensive care unit due to chest pain and syncope without any prodromal symptoms after taking the first doxazosin dose. Blood pressure was 100/60 mm Hg and heart rate was 100 bpm at initial evaluation. He had had hypertension for over ten years. He was on losartan. The electrocardiogram showed sinus rhythm with biphasic T wave on precordial derivations and negative T wave in leads DI and aVL (Figure 1 A). High-sensitivity troponin T level was elevated (42 ng/l, 0–14 ng/l). Kidney function tests were normal. A transthoracic echocardiogram showed left ventricular ejection fraction of 60% with normal wall motion, left ventricular hypertrophy, and diastolic dysfunction. Coronary angiography revealed that myocardial bridging was confined to the left anterior descending artery (LAD) with severe systolic compression (90%) (Figures 1 B, C). Other coronary arteries were normal. Doxazosin was discontinued. The patient was initially treated with metoprolol and aspirin. Myocardial perfusion scintigraphy was found to be normal under ?-blocker treatment. The protocol was performed at rest and during exercise, with 99mTc sestamibi. Cardiac enzyme level was decreased at follow-up. The patient was discharged with ?-blocker and acetylsalicylic acid. He has been followed up without any symptoms for 1 month. Discussion Coronary arteries that tunnel through the myocardium are seen in as many as 40% to 80% of cases on autopsy; however, functional MB is less commonly observed on angiography (0.5% to 16.0%) [1]. Although it is considered as a benign anomaly, it may lead to such complications as myocardial ischemia, acute coronary... View full text...
机译:简介心肌桥(MB)是一种解剖学变异,其特征是在心肌中运行的一些心外膜冠状动脉节段收缩期变窄。常规冠状动脉造影可在0.5%至16%的范围内遇到[1]。尽管它被认为是良性异常,但它可能导致诸如心肌缺血,急性冠状动脉综合征,冠状动脉痉挛,运动引起的心律失常(如室上性心动过速,室性心动过速,晕厥,甚至猝死)等并发症[2]。在本报告中,我们介绍了一个以前未曾报道的多沙唑嗪诱发的急性冠状动脉综合症的51岁男子,该人被诊断出左前降支上覆心肌桥接。病例报告一名51岁的男性因服用第一剂多沙唑嗪后因胸痛和晕厥而没有任何前驱症状,被送入冠心病重症监护病房。初始评估时血压为100/60 mm Hg,心率为100 bpm。他患有高血压已有十多年了。他正在服用氯沙坦。心电图显示窦性心律,心前区导联有双相性T波,导联DI和aVL呈负T波(图1 A)。高敏感性肌钙蛋白T水平升高(42 ng / l,0–14 ng / l)。肾功能检查正常。经胸超声心动图显示左心室射血分数为60%,壁运动正常,左心室肥大和舒张功能障碍。冠状动脉造影显示,心肌桥接局限于严重收缩压(90%)的左前降支(LAD)(图1 B,C)。其他冠状动脉正常。停止使用多沙唑嗪。该患者最初接受美托洛尔和阿司匹林治疗。在α-受体阻滞剂治疗下,发现心肌灌注显像正常。该方案是在休息和运动期间使用99mTc的司他米比进行的。随访时心脏酶水平降低。该患者出院时使用了β受体阻滞剂和乙酰水杨酸。对他进行了1个月的无症状随访。讨论在尸检中有多达40%至80%的病例可见穿过心肌的冠状动脉。但是,功能性MB在血管造影术上观察较少(0.5%至16.0%)[1]。尽管它被认为是良性异常,但它可能导致诸如心肌缺血,急性冠脉...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号